Introduction {#s1}
============

Like most other cell types, individual yeast cells display a finite lifespan as they undergo subsequent replication cycles and, due to their relative simplicity, have become a very fruitful model to study the causal interactions among the different hallmarks of cell aging. Since yeast daughter cells are rejuvenated during most of the mother cell lifespan, it is generally accepted that aging is the result of asymmetric segregation of factors such as extrachromosomal rDNA circles (ERCs), dysfunctional mitochondrial and vacuolar compartments, or resilient protein aggregates ([@bib10]; [@bib33]). Proteostasis deterioration is a universal hallmark of cellular aging ([@bib35]; [@bib36]; [@bib38]; [@bib43]), and yeast cells have been the paradigm to study the mechanisms of asymmetric segregation of protein aggregates or deposits and their relevance in aging ([@bib29]).

Molecular chaperones play key roles in proteostasis by folding nascent polypeptides, refolding misfolded proteins, and facilitating their degradation or accumulation in different types of aggregates and deposits if they cannot be properly recycled ([@bib26]). Yeast cells display an age-dependent protein deposit, termed APOD ([@bib58]), that appears early in their replicative lifespan and is retained in the mother cell compartment in every division cycle ([@bib29]). Several chaperones including Hsp104, Ssa1 and Ydj1 co-localize with the APOD ([@bib2]; [@bib27]; [@bib57]), where they are thought to play a concerted role in disaggregation and recycling of deposited proteins. Regarding asymmetric segregation of protein aggregates during cell aging, farnesylated Ydj1 has been shown to be important for proper retention of the APOD at the ER in the mother cell compartment ([@bib56]). The functional relevance of chaperones at the crossroads of protein aggregation and replicative aging is supported by the fact that Hsp104 and Ydj1 are required for a normal replicative lifespan and, when overexpressed, Hsp104 restores proteasome activity in aging cells ([@bib2]) and suppresses lifespan defects of *sir2* mutants ([@bib14]). Moreover, by counteracting protein aggregation, overexpression of metacaspase Mca1 extends the lifespan of yeast mother cells in a Hsp104- and Ydj1-dependent manner ([@bib27]).

The interdivision time of yeast cells increases during the last cycles before death ([@bib16]; [@bib40]; [@bib41]) and most aging cells accumulate in the unbudded period before death ([@bib9]; [@bib44]), suggesting that aging-related processes interfere with the mechanisms that trigger Start to drive cells into the cell cycle. The Cln3 cyclin is a rate-limiting activator of Start that is maintained at low but nearly constant levels during G1 ([@bib69]). Nuclear accumulation of Cln3 is driven by a constitutive C-terminal nuclear-localization signal (NLS) ([@bib13]; [@bib45]), but involves the essential participation of Ssa1 (or paralog Ssa2) and Ydj1 chaperones ([@bib70]) and the segregase activity of Cdc48 to release the G1 cyclin from the ER ([@bib53]). In addition, Ssa1 and Ydj1 also affect Cln3 stability ([@bib68]; [@bib72]), and their availability modulates the execution of Start as a function of growth and stress ([@bib46]). Here we study the effects of proteostasis decline during aging on the availability of Ssa1 and Ydj1 chaperones and, hence, on G1 cyclin function, aiming to uncover the processes that restrain proliferation in aged cells.

Results {#s2}
=======

Aging cells arrest mostly in G1 with low nuclear levels of cyclin Cln3 after the last budding event {#s2-1}
---------------------------------------------------------------------------------------------------

To analyze cell-cycle entry kinetics in the last generations prior to death, we first examined wild-type cells expressing Whi5-GFP ([@bib6]) in a CLiC microfluidics device ([Figure 1A](#fig1){ref-type="fig"} and [Video 1](#video1){ref-type="video"}) that had been developed for high-throughput analysis of single mother cells during aging ([@bib16]; [@bib23]). As previously observed, the average interdivision time was rather constant during aging until the senescence-entry point (SEP) ([@bib16]), when it displayed an abrupt increase that was maintained for ca. 2--3 generations on average prior to cell death ([Figure 1B](#fig1){ref-type="fig"}). The SEP concurred with an increase in the length of both unbudded (G1) and budded (S-G2-M) phases of the cycle. However, as assessed by the localization of Whi5 in the nucleus to inhibit the G1/S regulon ([@bib7]; [@bib6]), the G1 period prior to Start (T1) of the last three cycles before death displayed the largest relative increase compared to young mother cells ([Figure 1C](#fig1){ref-type="fig"}). Accordingly, while only about 15% of young mother cells are found in T1 in asynchronous cultures, the percentage of cells dying in this G1 subperiod increased up to ca. 75% ([Figure 1D](#fig1){ref-type="fig"}). Finally, old cells selected with the mother-enrichment program (MEP) displayed a larger fraction in G1 compared to young mother cells ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). These data point to the notion that the deleterious effects of aging on cell cycle progression are particularly severe in G1 and prior to Start.

![Yeast mother cells die mostly in G1 with low nuclear levels of cyclin Cln3.\
(**A**) A yeast mother cell (arrow) expressing Whi5-GFP during aging at the G1 phase of indicated cycles before death. (**B**) Interdivision times (mean ±CL, n = 50) aligned to the last budding event. (**C**) Cell-cycle period lengths (mean ±CL, n = 50) in aging cells relative to young cells. (**D**) Percentage (±CL, n = 50) of cells in G1 in young cycling cultures or at death. (**E**) Nuclear levels of Whi5-GFP during the last generations (numbers in open circles) before death (closed circle) of an aging mother cell. (**F**) Nuclear levels of Whi5-GFP (mean ±CL, n = 50) in aging cells as in panel E aligned at the last budding event. (**G--H**) Nuclear levels of mCtr-Cln3^11A^ as in panels (**E**) and (**F**). Shown p-values were obtained using a Mann-Whitney U test. Bar = 5 µm. Results shown in this figure are representative of two replicate experiments.\
10.7554/eLife.48240.004Figure 1---source data 1.Yeast mother cells die mostly in G1 with low nuclear levels of cyclin Cln3.](elife-48240-fig1){#fig1}

###### Movie of a representative Whi5-GFP (green) Hsp104-mCh (red) cell in the CLiC microfluidic chamber.

Images were taken every 10 min. The frame where the last budding event takes place is indicated.

10.7554/eLife.48240.005

Execution of Start is particularly sensitive to growth, and cells arrest in G1 when deprived of essential nutrients. Nonetheless, old cells grew in volume after the last budding event at same rate as in the previous cycle ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}) and, as a result of progressive lengthening of G1, their size rapidly increased during the last cycles before death ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). Our results agree with recent precise measurements of cell volume in aging cells until death in a different microfluidics device ([@bib59]). Overall, these data would rule out possible indirect effects of growth impairment on cell cycle progression in aging cells. On the other hand, the coefficient of variation in volume at the last budding event was 41.2%, while young cells displayed a reduced 20.2%, suggesting that cell size control at Start becomes less efficient as cells age.

To further characterize the observed defects in G1 progression in old mother cells, we carefully quantified the levels and localization of Whi5-GFP during the last cycles before death. In agreement with previous analyses of aging cells at the mRNA level ([@bib32]; [@bib75]), the overall cellular concentration of Whi5 did not change much during the last cycles ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}). The nuclear/cytoplasmic ratio oscillated normally in the previous cycles to the last budding event ([Figure 1E](#fig1){ref-type="fig"}), being high in G1 and low in the budded phases of the cycle due to Cdk-dependent phosphorylation and nuclear export of Whi5 ([@bib7]; [@bib6]). However, after the last budding event nuclear levels of Whi5-GFP remained low for about 200 min on average, and rose again to stay high in 76.8% of cells ([Figure 1F](#fig1){ref-type="fig"}), indicating that most cells completed the last cell cycle and arrested in the next G1 prior to death. Although the differences were not as large as previously reported ([@bib49]), Whi5 levels in the nucleus displayed a 3-fold increase during the last cycles and the final arrest in G1.

Cln3 is the most upstream G1 cyclin acting in the positive feedback loop that inactivates Whi5 and executes Start ([@bib65]; [@bib69]). Since Cln3 is too short-lived to be detected as a fluorescent-protein fusion in single cells, we used a hyperstable and hypoactive Cln3^11A^ protein fused to mCitrine (mCtr-Cln3^11A^) that can be detected by fluorescence microscopy with no gross effects on cell cycle progression ([@bib60]). As expected from its essential role in the nucleus, mCtr-Cln3^11A^ displayed a distinct nuclear signal during the last cycles before the final budding event ([Figure 1G,H](#fig1){ref-type="fig"}, and [Video 2](#video2){ref-type="video"}); however, the nuclear/cytoplasmic ratio decreased to very low levels afterwards and remained low until death. In agreement with the fact that *CLN3* mRNA levels do not show significant changes in aged cells ([@bib32]; [@bib75]), overall cellular levels of mCtr-Cln3^11A^ remained rather constant and similar to young cells ([Figure 1---figure supplement 1E](#fig1s1){ref-type="fig"}), ruling out major effects due to transcriptional or translational regulation of Cln3. In summary, our data suggest that aging cells would undergo profound alterations in the mechanisms that drive nuclear accumulation of cyclin Cln3 and, hence, delay G1 progression as observed in the last cycles before cell death.

###### Movie of a representative mCitrine-Cln3^11A^ (yellow) cell in the CLiC microfluidic chamber.

Images were taken every 10 min. The frame where the last budding event takes place is indicated.

10.7554/eLife.48240.006

Ssa1/Ydj1 chaperone function is compromised in aging cells {#s2-2}
----------------------------------------------------------

We have previously shown that chaperones play a key role in the mechanisms that regulate Cln3 localization ([@bib46]; [@bib53]; [@bib70]). Ssa1 and Ydj1, with the participation of Cdc48, are important for releasing the G1 Cdk-cyclin complex from the ER and promoting its nuclear accumulation to trigger Start. On the other hand, it is generally assumed that aged cells display severe defects in protein homeostasis, thereby leading to the accumulation of misfolded-protein aggregates ([@bib35]; [@bib36]; [@bib38]). Thus, we decided to analyze the levels of Ssa1, Ydj1 and Hsp104 fused to fluorescent proteins during aging in the CLiC microfluidics chamber. Levels of Ssa1 and Ydj1 chaperones were only slightly reduced during the last cycles before death when compared to young cells ([Figure 2A](#fig2){ref-type="fig"}). By contrast, Hsp104 concentration rose steadily during aging until the last budding event ([Video 1](#video1){ref-type="video"}), when it reached a two-fold increase compared to young cells, and continued to increase afterwards during the posterior G1 arrest at an even higher average rate ([Figure 2A](#fig2){ref-type="fig"}). To confirm this result with a different experimental approach we used the mother enrichment program (MEP) ([@bib41]) to select cells aged for ca. 20 generations and also observed an increase in Hsp104 concentration ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Observed changes in chaperone concentrations agree with previous analysis at the mRNA ([@bib75]) and protein ([@bib32]) levels, and suggest that cells sense proteostasis defects and, regarding to Hsp104, react during aging similarly to other stress instances in which chaperone availability is assumed to be temporarily compromised ([@bib8]). As their engagement in protein interactions must cause a decrease in the diffusion coefficient of chaperones, their mobility has been used as a proxy of availability ([@bib39]; [@bib46]; [@bib56]). Thus, we used MEP-aged cells to analyze the mobility dynamics of Ssa1 and Ydj1 chaperones as GFP fusions by fluorescence-loss in photobleaching (FLIP). Notably, we detected a dramatic drop in mobility of both Ssa1 and Ydj1 when we compared aged cells with their young counterparts ([Figure 2B,C](#fig2){ref-type="fig"}). This decrease was similar to that caused in young cells by L-azetidine-2-carboxylic acid (AZC), which induces the accumulation of misfolded proteins with chaperones into disperse cellular aggregates ([@bib15]), thus compromising chaperone availability. By contrast, free GFP did not display significant changes in its mobility in aged or AZC-treated cells ([Figure 2C](#fig2){ref-type="fig"}). Since AZC treatment rapidly hindered nuclear localization of mCtr-Cln3^11A^ ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), these data point to the notion that aged cells would be impaired in their ability to accumulate Cln3 in the nucleus due to severe limitations in chaperone availability.

![Mobility and spatio-temporal coincidence of Ssa1 and Ydj1 are reduced in aging cells.\
(**A**) Levels of Ssa1-mCh, Ydj1-GFP and Hsp104-mCh (mean ±CL, n = 50) in aging cells aligned at the last budding event. (**B**) FLIP analysis of Ssa1-GFP in representative young and old (MEP-aged) cells. (**C**) Mobility of Ssa1-GFP, Ydj1-GFP and GFP in MEP- cells aged for 24 hr (mid) or 48 hr (old), and young control or AZC-treated cells. Median ±Q (n = 40) values are also plotted. (**D**) Spatial autocorrelation function (ACF) by RICS for Ssa1-GFP. G(x), the ACF in the scanning direction, is indicated. (**E**) Average ACFs (n = 25) obtained by RICS for Ssa1-GFP in old (MEP-aged) and young cells. (**F**) Diffusion coefficients (open circles) obtained by RICS for Ssa1-GFP and Ydj1-GFP in old (MEP-aged) and young control or AZC-treated cells (n = 25). The results of Monte Carlo simulations (median ±Q, n = 66) are plotted. (**G**) Representative fluorescence intensity (top left) and brightness (B map, top right) images obtained by RICS for Ssa1-GFP. Ole1-mCh as ER reporter (bottom left) and merged (bottom right) images are also shown. (**H**) Representative brightness (**B**) maps obtained by RICS for Ssa1-mCh and Ydj1-GFP in old (MEP-aged) and young cells. Merged B maps with Ssa1-mCh (red) and Ydj1-GFP (green) are also shown. (**I**) Coincidence coefficients of Ssa1-mCh and Ydj1-GFP from B maps of old (MEP-aged) and young cells (n = 20), control and AZC-treated young cells (n = 10), and cells expressing GFP and mCh (n = 10). Median ±Q values are also plotted. Shown p-values were obtained using a Mann-Whitney U test. Bar = 2 µm. Results shown in this figure are representative of at least two replicate experiments.\
10.7554/eLife.48240.010Figure 2---source data 1.Mobility and spatio-temporal coincidence of Ssa1 and Ydj1 are reduced in aging cells.](elife-48240-fig2){#fig2}

To further analyze chaperone mobility during cell aging we used Raster-Image Correlation Spectroscopy (RICS) ([@bib12]) as an orthogonal approach. Briefly, RICS provides information on moving molecules from raster-scan confocal images by obtaining an autocorrelation function (ACF) from small arrays of pixels within the cell ([Figure 2D](#fig2){ref-type="fig"}). After fitting a free-diffusion model to the autocorrelation functions of Ssa1-GFP from young and aged cells ([Figure 2E](#fig2){ref-type="fig"}), a significant drop in the coefficient of diffusion (D) of Ssa1-GFP was detected in aged cells ([Figure 2F](#fig2){ref-type="fig"}), which was again similar to that observed in AZC-treated young cells. Moreover, a similar behavior was observed for Ydj1-GFP ([Figure 2F](#fig2){ref-type="fig"}).

The intersection value of autocorrelation functions obtained by RICS depends on a second parameter related to the number of fluorescent molecules in the moving particles, termed brightness (B). Interestingly, aged cells displayed lower B values for both Ssa1-GFP and Ydj1-GFP compared to young cells ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), which would reinforce the notion that the behavior of these two chaperones is altered in aged cells, perhaps as a result of different transient interaction dynamics. Contrary to the diffusion coefficient, which can only be robustly estimated after pooling data from many cells and images per cell, particle brightness can be determined rather consistently at a single-pixel resolution in every image to generate B maps. As shown in [Figure 2G](#fig2){ref-type="fig"}, Ssa1-GFP produced rather uneven B maps in young cells, displaying moving particles with more Ssa1-GFP molecules in compartments of the cell that did not particularly match the nucleus or the ER as assessed with an Ole1-mCh fusion ([Figure 2G](#fig2){ref-type="fig"}). We have recently described a procedure, called coincidence analysis ([@bib47]), that uses B maps to study the spatio-temporal colocalization of molecular pairs undergoing transient interactions when performing their function, such as Ssa1 and Ydj1. As previously observed, Ssa1-mCh and Ydj1-GFP displayed a much higher coincidence coefficient compared to free GFP and mCherry and, giving support to its application as a functional indicator of these two chaperones, their coincidence coefficient strongly decreased in the presence of AZC. Notably, B maps of Ssa1-mCh and Ydj1-GFP were more dissimilar in aged cells, and displayed a much lower coincidence coefficient compared to young cells ([Figure 2H,I](#fig2){ref-type="fig"}), suggesting that these two chaperones form less dynamic complexes in aged cells. All in all, these data point to the existence of important defects in the availability and concerted activity of Ssa1 and Ydj1, two key chaperones in the mechanisms that maintain protein homeostasis, in aged cells.

Firefly luciferase aggregation takes place during the G1 arrest preceding cell death {#s2-3}
------------------------------------------------------------------------------------

Firefly luciferase (FFL) refolding and enzymatic activity recovery has been widely used to assay chaperone activity in vitro ([@bib21]; [@bib61]) and in vivo ([@bib51]), and an FFL-GFP fusion has been used as a single-cell reporter of chaperone activity after protein denaturation by heat shock ([@bib1]). We first compared the aggregation state of FFL-GFP in young and MEP-aged cells and found that, while we were unable to detect clear FFL-GFP foci in young cells, ca. 40% of cells aged for 20--25 generations showed a variable number of FFL-GFP foci ([Figure 3A,B](#fig3){ref-type="fig"}), confirming the notion that aged cells accumulate misfolded-protein aggregates. We then analyzed the dynamics of FFL-GFP aggregation during aging in the CLiC microfluidics chamber, and developed the required algorithms in BudJ ([@bib17]) to delimit and quantify fluorescent-protein aggregates with precision ([Figure 3C](#fig3){ref-type="fig"}). We detected the first visible FFL-GFP foci around the last budding event, followed by an accelerated increase in the amount of FFL-GFP present in foci until death ([Figure 3D,E](#fig3){ref-type="fig"}). It is important to note that, while Hsp104-mCh colocalized with FFL-GFP foci induced by heat shock in young cells as expected, most FFL-GFP foci in aged cells did not colocalize with Hsp104-mCh in the APOD ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), indicating that the normally operating mechanisms of misfolded protein recycling are altered in advanced aging.

![Firefly luciferase aggregates become visible during the last cycle before cell death.\
(**A**) Representative images of FFL-GFP expressed from a regulatable promoter in young and old (MEP-aged) cells. (**B**) Percentage (±CL, n = 230) of young and old (MEP-aged) cells with FFL-GFP foci. (**C**) Representative image of an old (MEP-aged) cell expressing FFL-GFP (left) with the foci overlay (red) obtained from BudJ. (**D--E**) FFL-GFP levels in foci (n = 50) aligned at the last budding event. Individual (**D**) and mean ±CL (**E**) data are plotted. (**F**) Cellular and APOD Hsp104-mCh levels (mean ±CL, n = 50) in aging cells aligned at the last budding event. A representative aging cell (inset) at 0, 600 and 1200 min after the last budding event is shown. (**G**) Probability of FFL-GFP foci within the following 180 min (twice the generation time of young mother cells) after reading the relative Hsp104-mCh levels in the APOD. Sampled single-cell data (closed circles) and the logistic regression line (mean ±CL) are plotted, and the obtained odds ratio is indicated. Bar = 2 µm. Results shown in this figure are representative of two replicate experiments.\
10.7554/eLife.48240.013Figure 3---source data 1.Firefly luciferase aggregates become visible during the last cycle before cell death.](elife-48240-fig3){#fig3}

As previously mentioned, overall Hsp104-mCh levels increased much faster after the last budding event ([Figure 3F](#fig3){ref-type="fig"}). However, Hsp104-mCh levels in the APOD remained constant, leading to a reduction of the Hsp104-mCh fraction in the APOD relative to total levels. Notably, the fraction of Hsp104-mCh in the APOD correlated at a single-cell level with the appearance of FFL-GFP foci in the following 180 min ([Figure 3G](#fig3){ref-type="fig"}), indicating that Hsp104 would not be able to accumulate in the APOD much before FFL-GFP aggregates are clearly visible. Since Hsp104 levels increase under stress conditions known to affect protein folding, our data reinforce the notion of proteostasis defects becoming increasingly important after the last budding event.

Asymmetric aggregate inheritance predicts a decrease in chaperone availability and a G1 arrest in aging cells {#s2-4}
-------------------------------------------------------------------------------------------------------------

The asymmetric distribution of protein aggregates to the mother cell during cytokinesis is a key safeguard mechanism to produce rejuvenated daughter cells ([@bib29]). Thus, we established a stochastic model based on the asymmetric distribution of protein aggregates that appear stochastically during consecutive cycles of division, taking into account that chaperones are key factors in two mechanistic modules: (1) counteracting protein aggregation reactions and (2) facilitating nuclear accumulation of cyclin Cln3 to phosphorylate Whi5 and trigger Start ([Figure 4A](#fig4){ref-type="fig"}). Since Cln2 interacts with Ssa1,2 chaperones ([@bib22]) and likely requires chaperoning activities similar to Cln3 ([@bib17]; [@bib46]), the model used a simplified version of Start without the positive feedback loop, and made Start strictly dependent on Cln3. Model structure ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), reactions ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) and parameters ([Supplementary file 2](#supp2){ref-type="supplementary-material"}) were based on previous work by us ([@bib46]) as described in the Materials and methods section, and adjusted to obtain the replicative lifespan of wild-type cells, that is 30 cycles on average. First, we ran the model to simulate independent single cells, and stored all variables during consecutive cycles until a permanent G1 arrest was achieved, or up to a maximum time equivalent to 75 generations in wild-type cells under regular growth conditions. As shown in [Figure 4B](#fig4){ref-type="fig"}, simulated protein aggregates increased around the last budding event, causing a sharp decrease in available chaperones ([Figure 4C](#fig4){ref-type="fig"}) and free nuclear Cln3 ([Figure 4D](#fig4){ref-type="fig"}). Notably, all these simulated variables displayed kinetics qualitatively similar to the experimental data ([Figure 4B,E](#fig4){ref-type="fig"} *insets*). Simulated interdivision time in consecutive cycles remained rather constant, but progressively increased during the last generations before the final G1 arrest ([Figure 4E](#fig4){ref-type="fig"} and [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}), thus recapitulating the SEP ([@bib16]). Interestingly, the time when simulated levels of protein aggregates, available chaperones and free nuclear Cln3 initiated their respective changes closely correlated with the SEP ([Figure 4---figure supplement 2B--D](#fig4s2){ref-type="fig"}). Particularly for free nuclear Cln3 levels, which could be more precisely measured during the last division cycles before death, we observed a similar decrease to that predicted by the integrative model before and after the SEP ([Figure 4---figure supplement 2E](#fig4s2){ref-type="fig"}).

![Asymmetric aggregate inheritance predicts a decrease in chaperone availability and a G1 arrest in aging cells.\
(**A**) Scheme of the integrative mathematical model with chaperones playing concurrent roles in proteostasis and Start. (**B--E**) Predicted aggregate protein (**B**), available chaperone (**C**), and free folded Cln3 (**D**) levels and interdivision times in aging cells aligned at the last budding event. Values (mean ±CL, n = 75) are plotted as lines. Experimental (Exp) data from [Figures 1B, H](#fig1){ref-type="fig"}, [2F](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"} are also shown as insets for direct comparison.\
10.7554/eLife.48240.018Figure 4---source data 1.Asymmetric aggregate inheritance predicts a decrease in chaperone availability and a G1 arrest in aging cells.](elife-48240-fig4){#fig4}

Next we perturbed the parameters of the model ([Supplementary file 3](#supp3){ref-type="supplementary-material"}) to qualitatively predict the effects of genetic ablation of the relevant factors or modification of important conditions such as growth rate and cell size. The *cln3* mutant exhibited a shorter lifespan ([Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}) as described ([@bib27]; [@bib74]), while the *whi5* knockdown mutant showed the opposite behavior and lived longer than wild-type ([@bib74]). We also tested the effect of high and low growth rates in the model to simulate fast- and slow-growing cells. As experimentally observed ([@bib34]; [@bib74]), lifespan was strongly reduced by high growth rates ([Figure 4---figure supplement 3B](#fig4s3){ref-type="fig"}). Finally, since cell size has been proposed as a key factor affecting lifespan ([@bib74]), we performed independent simulations of cells with different initial cell volumes and obtained a clear dependence of lifespan on initial cell size ([Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}).

Cln3 overexpression increases replicative lifespan in a chaperone-dependent manner {#s2-5}
----------------------------------------------------------------------------------

The model predicted that increased levels of Cln3 would extend lifespan ([Figure 5A](#fig5){ref-type="fig"} inset). In order to measure the replicative lifespan of very large numbers of yeast cells we induced the MEP in cells growing in plates at low density, and obtained microcolonies with varying sizes that depended on the number of G2-arrested daughter cells produced by the mother cell during its replicative lifespan ([Figure 5---figure supplement 1A--C](#fig5s1){ref-type="fig"}). We first tested this experimental approach with wild-type and *cln3* cells ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}) and, as observed by conventional procedures ([@bib27]; [@bib74]), we found that Cln3 loss caused a ca. 40% reduction in lifespan. Next we used this approach to estimate the lifespan of cells overexpressing *CLN3* from a regulatable promoter and observed a remarkable increase in the relative lifespan compared to wild-type cells as predicted by the model ([Figure 5A](#fig5){ref-type="fig"}). Daughter cells overexpressing *CLN3* execute Start prematurely and bud at a smaller cell size ([Figure 5B](#fig5){ref-type="fig"}), which has been shown to have an effect on lifespan ([@bib74]). To avoid these effects, we activated *CLN3* expression at different times after MEP induction, and compared the effects of *CLN3* overexpression in young cells and cells pre-aged for 24 hr (12--15 generations) and 48 hr (25--30 generations), respectively. Overexpressing *CLN3* in pre-aged cells did not affect their budding size ([Figure 5B](#fig5){ref-type="fig"}), but produced a similar relative increase in lifespan ([Figure 5C](#fig5){ref-type="fig"}). Thus, higher levels of Cln3 were able to increase lifespan independently of cell size.

![Enforced expression of Cln3 increases lifespan in a chaperone-dependent manner.\
(**A**) Survival curves of control and *CLN3* overexpressing cells (n \> 300). Curves predicted by the integrative model in [Figure 4A](#fig4){ref-type="fig"} are also shown (inset). (**B**) Budding volume distributions (n \> 250) of young or old cells pre-aged for 24 hr before induction of *CLN3* expression. (**C**) Lifespan effects of *CLN3* overexpression in young (n = 200) or old cells pre-aged for 24 hr (n = 150) and 48 hr (n = 100). Median ±Q values are also plotted. (**D**) Survival curves of wild-type, Ydj1-deficient and *SSA1 YDJ1* overexpressing cells (n \> 300). Curves predicted by the integrative model in [Figure 4A](#fig4){ref-type="fig"} are also shown (inset). (**E**) Simulation of free Ydj1 and ProtM aggregate numbers during successive replicative cycles in wild-type cells by the integrative model. The results of a representative run in stochastic mode are shown. A 2-order of magnitude increase in Ydj1 levels (blue arrow) would only cause a very small delay (orange arrow) in protein aggregation and, as a consequence, in lifespan. (**F**) Lifespan of wild-type (wt) and Ydj1-deficient cells with empty vector (*ydj1*) or overexpressing *CLN3* (*ydj1 oCLN3*) (n = 150). Median ±Q values are also plotted. The plot on the right shows the predicted lifespan obtained from independent simulations (n = 75) for the corresponding genotypes. Shown p-values were obtained using a Mann-Whitney U test. Results shown in this figure are representative of at least two replicate experiments.\
10.7554/eLife.48240.021Figure 5---source data 1.Enforced expression of Cln3 increases lifespan in a chaperone-dependent manner.](elife-48240-fig5){#fig5}

While Ydj1-deficient cells displayed a reduced lifespan as previously observed ([@bib27]), concurrent overexpression of Ssa1 and Ydj1 did not increase lifespan significantly ([Figure 5D](#fig5){ref-type="fig"}). Albeit surprisingly, our model predicted that chaperone overexpression would have a very limited effect on lifespan ([Figure 5D](#fig5){ref-type="fig"} inset). By analyzing in detail the kinetics of Ydj1 levels and the appearance of protein aggregates in stochastic simulations ([Figure 5E](#fig5){ref-type="fig"}) we observed that, due the positive feedback loop inherent to autocatalytic aggregation, once the first protein aggregates appear they rapidly overcome Ydj1 levels by several orders of magnitude, thus making ineffective the relatively small (ca. 50%) increase in Ydj1 levels attained by GAL1p-driven overexpression ([@bib73]).

Finally, we analyzed the interdependencies of Cln3 and Ydj1 in lifespan determination. As shown in [Figure 5F](#fig5){ref-type="fig"}, overexpression of *CLN3* was able to suppress most of the lifespan reduction of the *ydj1* mutant compared to wild-type cells, these effects being qualitatively similar to those predicted by the integrative model. These data indicate that the molecular deficiencies produced by lack of Ydj1 with regards to lifespan can be greatly corrected by an excess of Cln3, and suggest that this G1 cyclin is a relevant chaperone client involved in cell aging. On the other hand, the effects of *CLN3* overexpression were also clearly attenuated by the *ydj1* deletion, indicating that higher levels of Cln3 require the Ydj1 chaperone to extend lifespan.

Protein aggregation in young mother cells delays G1 progression and hinders Cln3 function in the nucleus {#s2-6}
--------------------------------------------------------------------------------------------------------

Given the close temporal relationship observed between the appearance of FFL-GFP aggregates and the final G1 arrest in aging cells, we sought to investigate the effects of protein aggregation on the execution of Start in young cells. Hsp104, Ssa1 and Ydj1 chaperones regulate endogenous prion formation ([@bib63]). Thus, we fused a synthetic prion-forming domain (PFD) to GFP under the control of a regulatable promoter, and used a non-prion peptide derived from PFD with the same length and amino-acid composition but altered sequence as a control domain (CD) ([@bib66]). While these two peptides displayed similar disorder propensity, they exhibited very distinct prion-like properties ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). PFD, but not CD, produced SDS-resistant high-molecular-weight aggregates as assessed by agarose-gel electrophoresis ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Moreover, when expressed in young cells, only PFD-mCh formed foci where Ssa1-GFP, and to a much lesser extent Ydj1-GFP, also accumulated ([Figure 6A](#fig6){ref-type="fig"}). We then analyzed the effects of these synthetic peptides on chaperone mobility by FLIP as above, and found that only PFD expression caused a clear reduction in the mobility of both Ssa1-GFP and Ydj1-GFP ([Figure 6B](#fig6){ref-type="fig"}), which decreased even further for Ssa1-GFP in cells displaying PFD aggregates (PFD\*). These data suggest that PFD expression was able to compromise chaperone availability by sequestering Ssa1 in aggregates with low exchange rates. Next we analyzed the effects of heterologous protein aggregation on the nuclear localization of Cln3, and found that PFD overexpression was sufficient to decrease the nuclear levels of mCtr-Cln3^11A^ in a dose-dependent manner ([Figure 6C,D](#fig6){ref-type="fig"}). Consistent with these results, PFD overexpression increased the average budding size ([Figure 6E](#fig6){ref-type="fig"}). Sup35 is an endogenous yeast prion that accumulates in the APOD in aging cells ([@bib57]). Thus, we overexpressed the yeast prion Sup35N domain and observed an increase in the budding volume of cells that showed Sup35N aggregates similar to those with PFD aggregates ([Figure 6E](#fig6){ref-type="fig"}). In marked contrast, a Sup35N^m3^ mutant that does not form aggregates ([Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}) did not affect budding volume. More important, overexpression of Cln3 suppressed the increase in budding volume caused by PFD aggregation with no effects on aggregate frequencies ([Figure 6---figure supplement 1C,D](#fig6s1){ref-type="fig"}). Finally, since chaperones play important roles in proper coordination of budding size with growth rate ([@bib17]), we analyzed the possible effects of the accidental presence of PFD aggregates in daughter cells ([Figure 6F](#fig6){ref-type="fig"}). We observed that the presence of PFD aggregates did not alter ostensibly the average budding size of first-time mother cells, but the dependence on growth rate in G1 was greatly decreased as it had been observed in the *ydj1* mutant ([@bib17]), further suggesting that PFD aggregation affects Ydj1 availability.

![Protein aggregation hinders chaperone mobility and nuclear accumulation of Cln3 in young cells.\
(**A**) Representative young cells expressing the prion-forming domain (PFD)-mCh and either Ssa1-GFP or Ydj1-GFP. (**B**) Mobility of Ssa1-GFP, Ydj1-GFP and GFP in young cells expressing control CD or displaying PFD aggregates (\*). Ssa1-GFP mobility was also analyzed within PFD aggregates (\*\*). Median ±Q (n = 50) values are also plotted. (**C**) Representative images of young cells expressing mCtr-Cln3^11A^ and either CD or PFD. (**D**) Nuclear levels of mCtr-Cln3^11A^ in young cells as a function of CD (left) or PFD (right) expression levels. Single-cell (small circles), binned (mean ±CL, n = 10) data and the corresponding linear regression lines are plotted. Cells with PFD aggregates are indicated (red circles). (**E**) Budding volume of young cells expressing the indicated protein domains. Cells with PFD or Sup35N aggregates are indicated (\*). Median ±Q (n = 200) values are also plotted. (**F**) Budding volume of newborn daughter cells in the absence (left, n = 82) or presence (right, n = 42) of PFD aggregates after FACS selection as a function of growth rate in G1. Shown p-values were obtained using a Mann-Whitney U test. Bar = 2 µm. Results shown in this figure are representative of at least two replicate experiments.\
10.7554/eLife.48240.024Figure 6---source data 1.Protein aggregation hinders chaperone mobility and nuclear accumulation of Cln3 in young cells.](elife-48240-fig6){#fig6}

Lifespan shortening by protein aggregation is suppressed by overexpression of chaperones or Cln3 {#s2-7}
------------------------------------------------------------------------------------------------

To confirm the notion that proteotoxic aggregates limit replicative lifespan we expressed the abovementioned synthetic peptides in wild-type cells in the CLiC microfluidics chamber. Notably, PFD caused a dramatic decrease in lifespan, which was accentuated even more in mother cells showing PFD aggregates ([Figure 7A](#fig7){ref-type="fig"}). The frequency of cells in G1 at death also increased about 4-fold relative to young mother cells ([Figure 7B](#fig7){ref-type="fig"}), and there was a strong correlation between PFD concentration and the occurrence of death in the following 180 min ([Figure 7C](#fig7){ref-type="fig"}). By contrast, CD levels did not correlate at all with the timing of cell death ([Figure 7D](#fig7){ref-type="fig"}). Moreover, as previously observed with FFL-GFP in aging cells, PFD aggregation increased Hsp104 levels in young cells ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). However, different from aging cells, PFD and Hsp104 foci colocalized in young cells. Finally, budding size in PFD-expressing mother cells was larger in successive divisions compared to CD-expressing cells ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}), indicating longer delays in G1.

![Lifespan shortening by protein aggregation can be overcome by enforced expression of chaperones or Cln3.\
(**A**) Lifespan effects of CD or PFD expression in young cells in the CLiC microfluidics chamber (n = 50). Cells with PFD aggregates at the initial time point are indicated (\*). Median ±Q values are also plotted. (**B**) Percentage (±CL, n = 57) of PFD expressing cells in G1 in young cycling cultures or at death. (**C--D**) Last budding probability within the following 180 min (twice the generation time of young mother cells) after reading PFD (**C**) or CD (**D**) cell concentration. Sampled single-cell data (closed circles) and the logistic regression lines (mean ±CL) are plotted. Odds ratios are also indicated. (**E**) Predicted lifespan effects of *SSA1 YDJ1* overexpression and *CLN3* overexpression in PFD expressing cells (n = 75). Predicted values for control CD-expressing cells are shown as reference. Median ±Q values are also plotted. (**F--H**) Lifespan effects of concerted *SSA1 YDJ1* overexpression (**F**), duplication of seven chaperone genes (2 × 7CHP: *SSA1*, *YDJ1*, *HSP82*, *CDC37*, *CDC48*, *UFD1* and *NPL4*) (**G**) or *CLN3* overexpression (**H**) in PFD expressing cells (n \> 150). Values of control CD-expressing cells are shown as reference. Median ±Q values are also plotted. (**I**) By compromising chaperone availability, proteostasis deterioration would exclude cyclin Cln3 from the nucleus and, as a direct consequence, drive the cell into senescence. Shown p-values were obtained using a Mann-Whitney U test. Results shown in this figure are representative of at least two replicate experiments.\
10.7554/eLife.48240.027Figure 7---source data 1.Lifespan shortening by protein aggregation can be overcome by enforced expression of chaperones or Cln3.](elife-48240-fig7){#fig7}

Our data point to the notion that premature protein aggregation shortens replicative lifespan by compromising chaperone availability which, in turn, would hinder nuclear accumulation of cyclin Cln3 and progressively delay Start, leading the cell to an irreversible G1 arrest and death. To test this possibility further, we decided to analyze the effects of enforced chaperone or Cln3 expression in the lifespan of PFD-expressing cells. Notably, as predicted by our model ([Figure 7E](#fig7){ref-type="fig"}), we found that overexpression of *SSA1* and *YDJ1* from the dual *GAL1-10* promoter partially suppressed the lifespan reduction caused by PFD ([Figure 7F](#fig7){ref-type="fig"}), the lifespan being even closer to control CD-expressing cells when the copy number of seven chaperone genes (*SSA1*, *YDJ1*, *HSP82*, *CDC37*, *CDC48*, *UFD1*, *NPL4*) that cooperate in ER-release and proper Cdk-cyclin complex formation was duplicated ([Figure 7G](#fig7){ref-type="fig"}). Finally, also as predicted by the model ([Figure 7E](#fig7){ref-type="fig"}), the lifespan was totally comparable to control cells when PFD-expressing cells were subject to *CLN3* overexpression ([Figure 7H](#fig7){ref-type="fig"}). These results give additional support to the notion that protein aggregation in young cells leads to a premature G1 arrest by specifically inhibiting chaperone- and G1 cyclin-dependent execution of Start.

Discussion {#s3}
==========

It is generally accepted that aging cells undergo many different deleterious processes that somehow restrain proliferation and ultimately lead to cell death. However, their specific relevance and cause-effect relationships are just starting to emerge. Here we show that most yeast cells arrest in G1 before death and display low nuclear levels of cyclin Cln3, a key activator of Start that is particularly sensitive to chaperone status ([@bib46]; [@bib53]; [@bib70]). By using several independent approaches, we show that chaperone availability is seriously compromised in aged cells, and we find that blockade of cell-cycle entry finely correlates with the appearance of visible aggregates of a chaperone client reporter. A mathematical model integrating the role of chaperones in proteostasis and cyclin Cln3 activation is able to recapitulate our observations in aging cells. Notably, overexpression of Cln3 increases lifespan in a chaperone-dependent manner. As also predicted by the model, overexpression of aggregation-prone proteins in young cells decreases chaperone availability and restrains nuclear accumulation of Cln3 and, hence, cell-cycle entry. Finally, lifespan shortening by enforced protein aggregation can be suppressed by increased expression of specific chaperones or cyclin Cln3. Overall, these data establish a molecular mechanism linking loss of protein homeostasis to proliferation arrest in aged yeast cells.

Our data agree with the recent observation that expression of G1/S genes is greatly compromised in aged cells ([@bib49]), concurrently with an increase in the nuclear levels of Whi5. Since Whi5 is phosphorylated and exported to the cytoplasm by G1 Cdk-cyclin complexes ([@bib7]; [@bib6]), our observation that nuclear accumulation of mCtr-Cln3^11A^ is hindered in aging cells would explain, at least in part, the increase in nuclear Whi5 and the deficiencies in the activation of the G1/S regulon. Cells lacking Cln3 display a dramatic delay in G1, but do not arrest at Start unless *CLN1* and *CLN2* are disrupted ([@bib54]). Thus, the observed final G1 arrest should also involve other mechanisms restraining Cln1/2 levels or activity. It has been recently proposed ([@bib49]) that the accumulation of ERCs in aged cells ([@bib62]; [@bib64]) could have a direct inhibitory role on the *CLN2* promoter at the nuclear pore ([@bib37]). Interestingly, ERCs increase their levels around the time when G1 progression displays a clear delay ([@bib48]). As an alternative view, since Cln2 interacts with Ssa1,2 chaperones ([@bib22]) and likely requires chaperoning activities similar to Cln3 ([@bib17]; [@bib46]), our observations on Cln3 could also apply to basal levels of Cln1 and Cln2 and, hence, contribute to explaining the final G1 arrest.

Mitochondrial membrane potential has been shown to play a key role in dissolution of protein aggregates ([@bib55]; [@bib76]) and loss of membrane potential correlates with the SEP in a fraction of aging cells ([@bib16]). On the other hand, vacuolar acidity declines early during aging, and conditions that prevent this decline ameliorate mitochondrial function and extend lifespan ([@bib31]). Related to this, the vacuolar protein Vac17 has been shown to be involved in asymmetric segregation of protein aggregates ([@bib28]). Interestingly, we have observed that enforced protein aggregation in young cells increased vacuolar pH (our unpublished observations). These findings support the notion that mitochondrial defects, vacuolar dysfunction and accumulation of protein aggregates during aging would exhibit multiple functional interactions ([@bib29]), cell death being the result of many intertwined defects in key cellular processes. In addition, cells that keep growing while cell-cycle arrested undergo cytoplasmic dilution ([@bib50]), eventually contributing to a general breakdown of cellular homeostasis.

In our experiments with the CLiC microfluidics chamber, a fraction of cells (ca. 30%) were not arrested in G1 at death and showed a slightly shorter lifespan, which agrees with published findings ([@bib9]). PFD-overexpressing cells also displayed a similar percentage of death outside G1. Interestingly, enforced aggregation of the Rnq1 yeast prion causes a G2/M arrest with monopolar spindles ([@bib67]). In all, these observations suggest that proteostasis defects would also hinder cell-cycle progression and limit replicative lifespan after bud emergence.

Ydj1 cooperates with Hsp104 and Hsp70 chaperones to recycle misfolded proteins ([@bib21]), and improper recruitment of chaperones to misfolded proteins has very negative effects in lifespan ([@bib25]). In addition, Ydj1 associates with the APOD playing a key role in its asymmetric segregation to the mother compartment during cell division ([@bib57]; [@bib56]). Ydj1-deficient cells are particularly short-lived ([@bib27]), supporting the relevance of proteostasis mechanisms in lifespan determination. In agreement with this notion, overexpression of Hsp104 restores proteasome activity in aging cells ([@bib2]) and suppresses lifespan defects of *sir2* mutants ([@bib14]). However, enforced expression of Hsp104 did not increase lifespan significantly in wild-type cells ([@bib2]). We obtained similar results by concurrent overexpression of Ssa1 and Ydj1. Albeit surprisingly, our model predicted that chaperone overexpression would have a very limited effect on lifespan. This output of the model would be explained by (1) the positive feedback loop whereby proteostasis decline is accelerated by the autocatalytic accumulation of aggregated proteins ([@bib2]), and (2) the fact that client/chaperone ratios in molecule numbers per cell are intrinsically overwhelming. Nonetheless, the inability of chaperone overexpression to extend lifespan would also underscore the existence of chaperone-independent mechanisms affecting execution of Start in aged cells as above mentioned, such as ERC-mediated downregulation of G1/S genes ([@bib49]). On the other hand, *CLN3* overexpression suppresses the G1 progression delay of Ydj1-deficient cells with no effects on the expression of related chaperones ([@bib70]), and we show here that high levels of Cln3 rescue the short lifespan of Ydj1-deficient cells. These data give support to the downstream role of Cln3 with respect to chaperones in the proteotoxic aggregation pathway. This interplay between Cln3 and protein aggregates through chaperone availability is simulated in [Figure 7I](#fig7){ref-type="fig"}, where free Cln3 levels decay in aged cells as protein aggregates increase in an autocatalytic loop.

Aged cells display increased levels of expression of many genes of the environmental stress response (ESR) ([@bib32]; [@bib75]), which suggests that cells would sense proteostasis defects during aging similarly to other stress instances in which chaperone availability is assumed to be temporarily compromised ([@bib8]). Since many ESR genes are also upregulated in G0 cells obtained by nutrient starvation ([@bib20]), expression similarities between G0 and aged cells would be due to the ESR signature. However, *RIM15*, which is strongly upregulated by nutrient starvation but not by heat stress, is also upregulated in aged cells, indicating that G0 and aged cells might activate common transcriptional programs other than the ESR.

Proteostasis defects have been associated with cell aging in many different model organisms ([@bib36]), and the key factors that maintain the proteome in a conformationally-active state are exquisitely conserved. On the other hand, as in yeast, human G1 Cdk-cyclin complexes require the participation of chaperones also involved in general proteostasis ([@bib11]; [@bib24]). Thus, we foresee that mechanisms similar to those shown here for yeast cells could also play a prominent role in restraining proliferation in aging human cells.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                            Designation                   Source or\           Identifiers   Additional\
  or resource                                                                            reference                          information
  -------------------------------------------------------- ----------------------------- -------------------- ------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*Saccharomyces cerevisiae*)   BY4741                        Lab stock                          *MAT****a*** *his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG248                        This work                          *MAT****a*** *his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0 NAT::TEFp-GFP,* from S288C

  Strain, strain background\                               MAG261                        ([@bib46])                         *MAT****a*** *his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0 YDJ1-GFP-FS::HIS3,* from S288C
  (*S. cerevisiae*)                                                                                                         

  Strain, strain\                                          MAG1078                       This work                          *MAT****a*** *his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0 YDJ1-GFP-FS::HIS3 SSA1-mCherry::HYG,* from S288C
  background (*S. cerevisiae*)                                                                                              

  Strain, strain background (*S. cerevisiae*)              MAG1689                       This work                          *MAT****a*** *his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0 SSA1-GFP::HIS3 OLE1-mCherry::GEN,* from S288C

  Strain, strain background\                               YOR083W-GFP                   Lab stock                          *MAT**a** his3-Δ1 leu2Δ0 met15Δ0 ura3Δ0 WHI5-yGFP::HIS3,* from S288C
  (*S. cerevisiae*)                                                                                                         

  Strain, strain background\                               CML128                        ([@bib19])                         *MAT****a*** *leu2-3,112 ura3-52 trp1-1 his4-1 can^r^,* from 1788
  (*S. cerevisiae*)                                                                                                         

  Strain, strain background (*S. cerevisiae*)              MAG1077                       This work                          *MAT**a** leu2-3,112 ura3-52 trp1-1 his4-1 can^r^ WHI5-sGFP::GEN HSP104-mCherry::HYG,* from 1788

  Strain, strain background (*S. cerevisiae*)              MAG1512                       ([@bib46])                         *MAT****a*** *leu2-3,112 ura3-52 trp1-1 his4-1 can^r^ NAT::TEF1p-mCherry,* from 1788

  Strain, strain\                                          MAG1767                       This work                          *MAT****a*** *leu2-3,112 ura3-52 trp1-1 his4-1 can^r^ mCitrine-CLN3(11A)::NAT,* from 1788
  background (*S. cerevisiae*)                                                                                              

  Strain, strain\                                          MAG1767                       This work                          *MAT****a*** *leu2-3,112 ura3-52 trp1-1 his4-1 can^r^ HSP104-mCherry::HYG,* from 1788
  background (*S. cerevisiae*)                                                                                              

  Strain, strain background (*S. cerevisiae*)              UCC5179                       ([@bib41])                         *MAT**a** ade2::hisG his3*\
                                                                                                                            *leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1013                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX (ARS-CEN URA3 HSP104 SSA1 YDJ1 HSC82 CDC37 CDC48 UFD1 NPL1),* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1095                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX YDJ1-GFP-FS::HIS3,* from S288C

  Strain, strain\                                          MAG1096                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX SSA1-GFP::HIS3,* from S288C
  background (*S. cerevisiae*)                                                                                              

  Strain, strain background (*S. cerevisiae*)              MAG1578                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX loxP-UBC9*\
                                                                                                                            *-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX ydj1Δ::GEN,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1745                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX*\
                                                                                                                            *loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX YDJ1-GFP-FS::HIS3 SSA1-mCherry::KAN,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1952                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::*\
                                                                                                                            *SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX Hsp104-mCherry::GEN,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG2060                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX*\
                                                                                                                            *loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX GAL1p-CLN3 URA3::TRP1,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1253                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX*\
                                                                                                                            *loxP-UBC9-loxP-LEU2*\
                                                                                                                            *loxP-CDC20-intron-loxP-HPHMX trp1Δ63::SCW11pr-Cre-EBD78*\
                                                                                                                            *-KanMX4,* from S288C

  Strain, strain background\                               MAG1569                       This work                          *MAT**a** ade2::hisG his3 leu2*\
  (*S. cerevisiae*)                                                                                                         *lys2 ura3Δ0 trp1Δ63 hoΔ::*\
                                                                                                                            *SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX trp1Δ63::SCW11pr-Cre-EBD78-*\
                                                                                                                            *KanMX4 CLB2-GFP::HIS3MX,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1576                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX trp1Δ63::SCW11pr-Cre-EBD78-KanMX4 CLB2-GFP::HIS3 GALp-CLN3-URA3::TRP1,* from S288C

  Strain, strain background (*S. cerevisiae*)              MAG1795                       This work                          *MAT**a** ade2::hisG his3 leu2 lys2 ura3Δ0 trp1Δ63 hoΔ::SCW11pr-Cre-EBD78-NatMX*\
                                                                                                                            *loxP-UBC9-loxP-LEU2 loxP-CDC20-intron-loxP-HPHMX trp1Δ63::SCW11pr-Cre-EBD78-KanMX4 CLB2-GFP::HIS3MX Δcln3::URA3MX,* from S288C

  Strain, strain background (*S. cerevisiae*)              W303-1A                       Lab stock                          *MAT****a*** *ade2-1 trp1-1 leu2-3,111 his3-11,75 ura3 can1-100,* from W303

  Strain, strain background (*S. cerevisiae*)              KSY083-5                      ([@bib60])                         *MAT**a** ADE2 trp1-1 leu2-3,111 his3-11,75 ura3 can1-100 mCitrine-CLN3-11A::NAT*

  Strain, strain background (*S. cerevisiae*)              MAG876                        This work                          *MAT****a*** *ade2-1 trp1-1 leu2-3,111 his3-11,75 ura3 can1-100 SSA1-GFP::HIS3,* from W303

  Recombinant DNA reagent                                  YCplac22                      Lab stock                          Centromeric *TRP1* vector

  Recombinant DNA reagent                                  YCplac33                      Lab stock                          Centromeric *URA3* vector

  Recombinant DNA reagent                                  YCpGAL                        Lab stock                          *GAL1/10* p in YCplac22

  Recombinant DNA reagent                                  p425MET25-FFL-GFP             ([@bib1])                          *MET25p-FFL-GFP* in pRS425

  Recombinant DNA reagent                                  pCYC87                        Lab stock                          *GAL1/10p-CLN3-3HA* in YCplac33

  Recombinant DNA reagent                                  pMAG438                       ([@bib46])                         *SSA1 YDJ1 HSC82 CDC37 CDC48 UFD1 NPL4* in YAC *URA3*

  Recombinant DNA reagent                                  pMAG600                       This work                          *GAL1/10p-Sup35Nm3-GFP* in YCplac22

  Recombinant DNA reagent                                  pMAG602                       This work                          *GAL1/10p-PFD-GFP* in YCplac22

  Recombinant\                                             pMAG604                       This work                          *GAL1/10p-CD-GFP* in YCplac22
  DNA reagent                                                                                                               

  Recombinant DNA reagent                                  pMAG605                       This work                          *GAL1/10p-Sup35N-GFP* in YCplac22

  Recombinant DNA reagent                                  pMAG610                       This work                          *GAL1/10p-GFP* in YCplac22

  Recombinant DNA reagent                                  pMAG633                       This work                          *GAL1/10p-PFD-mCh* in YCplac33

  Recombinant DNA reagent                                  pMAG634                       This work                          *GAL1/10p-CD-mCh* in YCplac33

  Recombinant DNA reagent                                  pMAG1182                      This work                          *GAL1p-SSA1 GAL10p-YDJ1* in YCplac33

  Recombinant DNA reagent                                  pMAG1228                      Lab stock                          *TE1Fp-GFP* in YCplac33

  Antibody                                                 αGFP (Mouse monoclonal)       Merck                G1546         

  Chemical compound, drug                                  Azetidine-2-carboxilic acid   Sigma-Aldrich        A0760         

  Chemical compound, drug                                  β-estradiol                   Sigma-Aldrich        E2758         

  Software, algorithm                                      MODEL1901210001               This work                          BioModels database

  Software, algorithm                                      ImageJ                        Wayne Rasband, NIH                 [imagej.nih.gov/ij/download.html](https://imagej.nih.gov/ij/download.html)

  Software, algorithm                                      BudJ                          ([@bib17])                         [ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry](http://www.ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry)

  Software, algorithm                                      CoinRICSJ                     ([@bib47])                         [ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry](http://www.ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry)

  Software, algorithm                                      RICS analysis plugins         Jay Unruh,\                        [research.stowers.org/imagejplugins](https://research.stowers.org/imagejplugins/)
                                                                                         Stowers Institute                  

  Software, algorithm                                      Microcolony_size.ijm          This work                          [ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry](http://www.ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry)

  Software,\                                               PAPA                          ([@bib66])                         [combi.cs.colostate.edu/supplements/papa](http://combi.cs.colostate.edu/supplements/papa/)
  algorithm                                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Strain constructions and growth conditions {#s4-1}
------------------------------------------

Parental strains and methods used for chromosomal gene transplacement and PCR-based directed mutagenesis have been described ([@bib17]). Unless stated otherwise, all gene fusions in this study were expressed at endogenous levels at their respective loci. As C-terminal fusion of GFP or other tags has strong deleterious effects on Ydj1 function, we inserted GFP at amino acid 387, between the dimerization domain and the C-terminal farnesylation sequence of Ydj1. This construct had no detectable effects on growth rate or cell volume when expressed at endogenous levels ([@bib56]). The mCitrine-Cln3^11A^ fusion protein contains a hypoactive and hyperstable cyclin with 11 amino acid substitutions (R108A, T420A, S449A, T455A, S462A, S464A, S468A, T478A, S514A, T517A, T520A) that allows its detection by fluorescence microscopy with no gross effects on cell cycle progression ([@bib60]). Centromeric plasmids and yeast artificial chromosomes containing chaperone genes were obtained by multiple-fragment recombination ([@bib46]). Cells were grown for 7--8 generations in SC medium with 2% glucose at 30°C unless stated otherwise. GAL1p-driven gene expression was induced by addition of 2% galactose to cultures grown in 2% raffinose at OD600 = 0.5. 1 µM β-estradiol was used to activate the Mother Enrichment Program (MEP) as described ([@bib41]). Azetidine 2-carboxylic acid (AZC) was used at 10 mM.

Time-lapse microscopy {#s4-2}
---------------------

Cells were analyzed by time-lapse microscopy within the CLiC microfluidic device as described ([@bib16]) in SC-based media at 30°C essentially as described ([@bib17]) using a fully-motorized Leica AF7000 microscope with a 63X/1.3NA oil-immersion objective. The media was pumped into the microfluidic device at a rate of 20 μL/min. Time-lapse images were taken every 10 min. Time-lapse images were analyzed with the aid of BudJ ([@bib17]), an ImageJ (Wayne Rasband, NIH) plugin that can be obtained from ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry to obtain cell dimensions and fluorescence data as described ([@bib17]); budding events were identified visually. Wide-field microscopy is able to collect the total fluorescence emitted by yeast cells and, consequently, cellular concentration of fluorescent fusion proteins was obtained by dividing the integrated fluorescence signal within the projected area of the cell by its volume. The nuclear compartment was delimited as described ([@bib17]). Briefly, the gravity center from brightest pixels in the cell was used as center of a projected circle with area equal to that expected for the nucleus (17% of the cell projected area). Since the signal in the nuclear projected area is influenced by both nuclear and cytoplasmic fluorescence, determination of the nuclear concentration required specific calculations as described ([@bib46]). Intracellular foci were detected with BudJ as pixels with a fluorescence value above a certain threshold relative to the median cell fluorescence that produced a contiguous area with a minimum size (both set by the user). In a typical set up, pixels were selected if at least 30% brighter than the cell median, with a minimal size of 0.4 μm. Photobleaching during acquisition was negligible (less than 0.1% per time point) and autofluorescence was always subtracted.

Biotin labeling of the cell wall for aged cells detection {#s4-3}
---------------------------------------------------------

MEP-derived cells were labeled with Sulfa-NHS-LC-Biotin (Pierce) as described ([@bib41]), and seeded in SC medium with 1 µM β-estradiol. After ageing for 1 or 2 days, cells were collected using a 0.2 μm pore centrifuge filter and a soft spin. Cells were washed twice with PBS in the column and stained with a Streptavidin-APC conjugate solution (2 μg/ml in PBS) for 30 min at 4°; simultaneously, bud scars were labeled with a compatible WGA-conjugated fluorochrome at 20 μg/ml. Afterwards cells were washed twice with media and transferred to 35 mm glass-bottom culture dishes (GWST-3522, WillCo) before microscopy.

Chaperone mobility analysis by FLIP and RICS {#s4-4}
--------------------------------------------

We used fluorescence loss in photobleaching (FLIP) to analyze chaperone mobility in a Zeiss LSM780 confocal microscope with a 40X/1.2NA water-immersion objective at room temperature. FLIP was used as a qualitative assay to determine Ssa1-GFP and Ydj1-GFP mobility in the whole cell. A small circular region of the cytoplasm (3.6 µm^2^) was repetitively photobleached at full laser power while the cell was imaged at low intensity every 0.5 s to record fluorescence loss. After background subtraction, fluorescence data from an unbleached cell region were made relative to the initial time point, and a mobility index was calculated as the inverse of the fluorescence half-life obtained by fitting an exponential function. We noticed a clear dependency of this mobility index on cell size. Using a dataset of cells with very wide size range and expressing free GFP, we obtained an expression to correct the mobility index for cell size with *MI~c~ = MI .r^1.49^* where *MI* is the raw mobility index, *r* is the cell radius and *MI~c~* is the corrected mobility index ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

Raster Image Correlation Spectroscopy (RICS) analysis was performed in a Zeiss LSM780 confocal microscope with a 63X/1.3NA water-immersion objective; specifically, we used a 35 nm pixel size and 12.6μs dwell time, tacking a stack of 100 frames (2 s/frame) in photon-counting detection mode, at room temperature. To obtain the coefficient of diffusion, 64 × 64 pixel stacks were used to remove the immobile fraction with a five frame moving average and analyzed using a set of plugins written by Jay Unruh (Stowers Institute) for ImageJ. The resulting autocorrelation function (ACF) in the scanning direction, that is G~RICS~(ξ,0), for each cell was obtained and averaged for each group of cells to determine the diffusion coefficient (D) and the number of molecules in the focus (N) by fitting the data to a simple diffusion model. In order to assess the uncertainty of the predicted D values from pooled RICS data by non-linear regression methods we used a Monte Carlo approximation.

Coincidence analysis with RICS data was carried out with CoinRICSJ ([@bib47]). Briefly, after removal of the immobile fraction as described above, the ACF of each pixel was obtained using a 16 pixel range only in the raster direction. The intercept obtained by linear regression of the ACF (no specific model of diffusion assumed) was used as an approximation of the inverse of the number of moving particles (N). Then, the fluorescence intensity (I) at each pixel was used calculate the brightness (B) parameter as B = I/N, which were assembled into B maps covering the whole image being analyzed. Finally, correlation between Bmaps was analyzed using the Pearson's correlation coefficient, setting the threshold as the mean value in the B map. These correlation coefficients assess the degree of spatiotemporal coincidence of moving particles of the two proteins analyzed as a function of the number of fluorescent molecules per particle ([@bib47]).

Lifespan analysis by MEP-induced microcolony size {#s4-5}
-------------------------------------------------

MEP strains were grown as above, diluted to OD600 = 0.01, and plated in 500 μL at \~3·10^4^ cfu/cm^2^ onto 35 mm 2% agar plates containing SC medium with 2% glucose or 2% galactose and 1 µM β-estradiol. Once the plates were dry, they were incubated at 30°C for 4 days. Finally, the microcolonies were imaged using a Leica AF7000 microscope with a 20X/0.5NA dry objective. As a proof of concept for the method, we measured the microcolony size produced by cells pre-aged in liquid media with 1 µM β-estradiol for increasing amounts of time, and we observed a progressive decrease in microcolony size as a function of pre-aging time in liquid media before plating ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). The microcolony area was determined semiautomatically using an ImageJ macro (microcolony_size.ijm). Briefly, after thresholding and binarization, segmentation of adjacent microcolonies with the watershed function, and exclusion of the objects at the edge of the image, the area of particles (holes included) was measured. Microcolonies that were too small (with less than 4--5 cell bodies) or too big (microcolonies where cells had likely escaped from the MEP) were filtered out.

Integrative mathematical model {#s4-6}
------------------------------

The wiring diagram used to describe the interaction between Start and the protein folding/aggregation pathway is described in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. We chose to focus only upon execution of Start because experimentally we found that over 75% of aging cells arrest in G1 before death. To simulate the rest of the cell cycle we run a fixed timer. The Start network was also simplified to a constantly diluting ([@bib60]) Whi5 molecule that is phosphorylated and inactivated by fluctuating Cln3 ([@bib42]), which requires the concerted action of Ssa1 and Ydj1 chaperones for full activation ([@bib70]). Thus, execution of Start was modeled to take place when a minimal Whi5 threshold was reached. [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} also details the wiring diagram used to describe the protein aggregation pathway. This again is a simplified approximation and includes dimers (which are assumed to represent a pool of all non-nucleated oligomers) and hexamers (which are assumed to represent a pool of all nucleated oligomers). This drastically decreases the number of species in the model and the complexity of the system, and we specifically chose hexamers to represent the nucleated form as they appear to have a critical size for stabilization of the oligomer in aggregating proteins ([@bib4]; [@bib71]). The Hsp104 disaggregase is required for disassembling large aggregates and works in conjunction with Ssa1 and Ydj1 chaperones ([@bib52]). It is therefore included in the dissociation of nucleated aggregates (hexamers), but not in monomer or dimer refolding. Ssa1 and Ydj1 are also able to suppress aggregation, presumably by refolding monomers and other small oligomers that are not nucleated, so we allow the Ssa1/Ydj1 chaperones to bind and refold these states. It is assumed that refolding always adds to the folded protein pool and that chaperones are not released until the misfolded proteins are either degraded or obtain their correct conformation.

The wiring diagram was converted into a model using COPASI ([@bib30]) with chemical reactions shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. All chemical reactions are assumed to follow mass-action kinetics and, hence, every catalyst is placed on both sides of the chemical equation. However, we explicitly create states where the Ssa1/Ydj1 chaperones are bound to the protein, as opposed to acting as a catalyst, as this allows us to follow the pool of chaperones bound to protein aggregates. Regarding the chemical equations involving the chaperone, we take into account that larger aggregates bind more chaperones and assume a 1:1 chaperone to protein ratio. Following experimental observations, Hsp104 disaggregase is given a background concentration that increases upon accumulation of chaperone-hexamer complexes. We choose to model Hsp104 as a catalyst that does not have multiple bound and unbound states for simplicity.

In order to create full cell cycles, events were included to simulate Start and cell division when specific conditions are met. Inactivation of the Whi5 inhibitor by Cln3 is what triggers Start in the model. We assume that Whi5 has a decaying concentration during G1 ([@bib60]) and, arbitrarily, Start is executed when 75% of Whi5 molecules are inactivated. The remainder of the cell cycle is assumed to take a constant time for simplicity. At division nuclear Cln3 is set to zero and Whi5 to the same initial Whi5 concentration in the previous generation, thus replicating the result that as cells age, the number of Whi5 molecules observed at the beginning of G1 increases with the increase in cell size ([@bib49]).

Parameter selection was completed by scanning the parameter space using deterministic simulations in COPASI so that the average replicative lifespan matched the average value observed in experiments with wild-type cells. We then perturbed the model parameters by 1, 10% and 25% to obtain various cell cycle mutants, as described in [Supplementary file 3](#supp3){ref-type="supplementary-material"}. The most biologically accurate perturbation for each mutant in deterministic simulations was used for all subsequent simulations in stochastic mode. We also ensured that the parameters produced biologically accurate values for Ssa1/Ydj1, Wh5 and Cln3 (10000, 1000, and 100 molecules per cell, respectively). In order to speed up simulations, overall folded protein was limited to 10^5^ molecules per cell by increasing degradation of the folded protein pool, which is the final product of the process and does not affect the results of the model. Once the most biologically accurate parameter set was selected, time course simulations were run using a direct stochastic method that implemented the Gillespie algorithm to simulate aggregation as a stochastic process. The stochastic time-course simulations were run 75 times for each condition, in order to obtain the distribution and average of replicative lifespans. The final parameter set is listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. Due to the existence of backup mechanisms for *CLN3* (basal expression of *CLN1,2*) or *YDJ1* (*SIS1*), genetic ablation of these genes was simulated by applying different degrees of reduction in the concentrations of the respective proteins ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Increases and decreases in parameters were selected by conducting parameter sensitivity analysis in deterministic mode at 1, 10, 25% intervals after which the most biologically accurate perturbation was selected for stochastic simulations in each scenario. Initial sizes of mutants are based upon experimental data ([@bib17]).

Miscellaneous {#s4-7}
-------------

DNA-content distributions were obtained by Fluorescence Activated Cell Sorting ([@bib19]), with slight modifications to identify aged mother cells with labeled cell wall (see above) in a Gallios Flow Cytometer. Protein extracts were analyzed by SDS-PAGE ([@bib19]) or under semi-denaturing conditions to preserve amyloid aggregates by SDD-AGE ([@bib3]). Immunoblot analysis with αGFP was performed as described ([@bib19]).

Statistical analysis {#s4-8}
--------------------

Sample size is always indicated in the figure legend and, unless stated otherwise, median and quartile (Q) values are shown in all plots with single-cell data. Pairwise comparisons were performed with a Mann-Whitney U test; and the resulting p values are shown in the corresponding figure panels. For percentages, 95% confidence limits (CL) are always shown. Time-lapse data recorded from single cells in the CLiC microfluidics chamber are represented as the mean value of the population along time (with cells aligned at last budding event), while the shadowed area represent the 95% confidence limits of the mean. Logistic regression analysis was performed with the aid of a Java applet developed by J.C. Pezzullo ([statpages.info/logistic.html](https://statpages.info/logistic.html)).

Data and software availability {#s4-9}
------------------------------

The model was deposited in the BioModels ([@bib5]) database as MODEL1901210001 in SBML format and a COPASI ([@bib30]) file to reproduce simulations with the parameter set shown in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. BudJ ([@bib17]), CoinRICSJ ([@bib47]) and the microcolony_size macro can be obtained as ImageJ (Wayne Rasband, NIH) plugins from [ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry](http://www.ibmb.csic.es/groups/spatial-control-of-cell-cycle-entry). Jay Unruh's plugins can be obtained from [research.stowers.org/imagejplugins](https://research.stowers.org/imagejplugins/). Prion propensity plots were obtained by the PAPA software ([@bib66]) located at combi.cs.colostate.edu/supplements.
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Thank you for submitting your article \"Proteostasis collapse halts G1 progression and delimits replicative lifespan\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Yves Barral as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by David Ron as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Thomas Nyström (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary

In this study, Moreno et al. establish that old yeast mother cells show a strong increase in proteostasis defects in their last divisions, as measured by chaperone mobility, levels and localisation. In parallel, these cells fail to properly fold the G1 cyclin Cln3, as reported by its failure to enter the nucleus, and the majority of the cells arrest their last cell cycle in the G1 phase of the cell cycle before dying. Cells induced to accumulate an aggregating protein show a similar increase in proteostasis defects, defect in Cln3 localisation to the nucleus and cell cycle arrest in G1. Based on a quantitative in silico model of this process, model that is is largely corroborated by the data, the authors propose that the collapse of proteostasis titrates the chaperones that normally ensure the proper activity and localisation of Cln3 and thereby lead to cell cycle arrest. Supporting this model, CLN3 over-expression extends the life-span of these cells. All three reviewers found that this manuscript is very well written, the experimental design is generally appropriate for testing the authors\' hypotheses, and the experiments are well executed and convincing.

Essential revisions

The fact that CLN3 over-expression extends the longevity of the cells whereas overexpression of the chaperones does not is actually confusing. This seems at odds with the statement that chaperones are the limiting factor -- does overproduction of Cln3 bypass the need for chaperones or what is going on? Does CLN3 over-expression promote expression of chaperones? If this is not the case, then the model needs to be amended at this time as it might not be as straightforward, and linear, a relationship as the authors suggest. Indeed, this observation could support two independent conclusions: Either proteostasis defects are accumulating more rapidly than any chaperone increase could control (and then it would be interesting to understand why), or one or several other processes limit the lifespan of the cell together with proteostasis and are not mitigated by chaperone over-expression.

Depending on the results of the additional experiments requested, the title of the paper might need to be amended.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Proteostasis collapse halts G1 progression and delimits replicative lifespan\" for further consideration at *eLife*. Your revised article has been favorably evaluated by David Ron (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

While there is clear enthusiasm about your study and its findings, the reviewers were still unanimously concerned about whether the overall conclusion, as claimed in the title is truly supported by the data. The fact that Cln3 over-expression does prolongate the lifespan of wild type cells is a very interesting and important finding. However, the fact that chaperone over-expression does not show such effect remains a strong concern, and this is for two reasons.

1\) It raises the question of whether the proteostasis collapse is THE process that delimits the replicative lifespan of yeast cells, i.e., is the ultimate cause of the death of the cells. Indeed, proteostasis defects could also be a symptom of another defect, which could be the actual lethal event. You very clearly show that proteostasis collapse can be lethal, as many other events, but you also clearly show that in that case chaperon over-expression does restore longevity. This strongly undermines the arguments made on the basis of in silico modelling.

2\) It raises issues about the interpretation of how Cln3 over-expression promotes longevity. Indeed, if proteostasis collapse is the lethal event, how would cell cycle progression allow cells to escape it, in the context of your model of an exponential accumulation of unfolded proteins?

Therefore, the reviewers decided to insist on their request that you investigate whether CLN3 over-expression promotes chaperon expression. If this were not to be the case, the reviewers would find it more appropriate to discuss the issue more thoroughly and tone down the main conclusion of the paper.

10.7554/eLife.48240.034

Author response

> Essential revisions
>
> The fact that CLN3 over-expression extends the longevity of the cells whereas overexpression of the chaperones does not is actually confusing. This seems at odds with the statement that chaperones are the limiting factor -- does overproduction of Cln3 bypass the need for chaperones or what is going on? Does CLN3 over-expression promote expression of chaperones? If this is not the case, then the model needs to be amended at this time as it might not be as straightforward, and linear, a relationship as the authors suggest. Indeed, this observation could support two independent conclusions: Either proteostasis defects are accumulating more rapidly than any chaperone increase could control (and then it would be interesting to understand why), or one or several other processes limit the lifespan of the cell together with proteostasis and are not mitigated by chaperone over-expression.

As also suggested by the reviewers in their last minor point, we have added to main Figure 5 our data and model simulations corresponding to chaperone overexpression in aging cells. We have modified the text (subsection "Cln3 overexpression increases replicative lifespan in a chaperone-dependent manner" and Discussion paragraph five) to describe these data as follows: While Ydj1-deficient cells displayed a reduced lifespan as previously observed (Hill et al., 2014), concurrent overexpression of Ssa1 and Ydj1 did not increase lifespan significantly (Figure 5D). Albeit surprisingly, our model predicted that chaperone overexpression would have a very limited effect on lifespan (Figure 5D inset). By analyzing in detail the kinetics of Ydj1 levels and the appearance of protein aggregates in stochastic simulations (Figure 5E) we observed that, due the positive feedback loop inherent to autocatalytic aggregation, once the first protein aggregates appear they rapidly overcome Ydj1 levels by several orders of magnitude, thus making ineffective the relatively small (ca. 50%) increase in Ydj1 levels attained by GAL1p-driven overexpression (Yahya et al., 2014).

In addition, in the Discussion section (paragraph five) we mention that, similarly to our results with Hsp70/40, overexpression of Hsp104 restores proteasome activity in aging cells (Andersson et al., 2013) and suppresses lifespan defects of sir2 mutants (Erjavec et al., 2007), but does not increase lifespan significantly in wild-type cells (Andersson et al., 2013).

Finally, as we discuss in Discussion paragraph two, the accumulation of ERCs in aged cells (Shcheprova et al., 2008; Sinclair and Guarente, 1997) may play a more direct role repressing CLN1,2 expression (Neurohr et al., 2018). This would explain why, regarding lifespan extension, CLN3 overexpression is much more efficient than increasing chaperone expression levels.

> Depending on the results of the additional experiments requested, the title of the paper might need to be amended.

We believe that, considering also our data above, the title reflects the main findings of our work, particularly in view of the important effects caused by precocious PD-protein aggregation in lifespan, and their suppression by either G1-cyclin or chaperone overexpression.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> While there is clear enthusiasm about your study and its findings, the reviewers were still unanimously concerned about whether the overall conclusion, as claimed in the title is truly supported by the data. The fact that Cln3 over-expression does prolongate the lifespan of wild type cells is a very interesting and important finding. However, the fact that chaperone over-expression does not show such effect remains a strong concern, and this for two reasons.
>
> 1\) It raises the question of whether the proteostasis collapse is THE process that delimits the replicative lifespan of yeast cells, i.e., is the ultimate cause of the death of the cells. Indeed, proteostasis defects could also be a symptom of another defect, which could be the actual lethal event. You very clearly show that proteostasis collapse can be lethal, as many other events, but you also clearly show that in that case chaperon over-expression does restore longevity. This strongly undermines the arguments made on the basis of in silico modelling.

We agree with your first point that, although we find very strong temporal correlations, our data do not demonstrate that proteostasis collapse is THE reason why cell proliferation declines and cells arrest in G1 before death. We also accept that the initially proposed title was a bit ambiguous in this respect and we propose a new title as follows: "Proteostasis collapse, a hallmark of aging, hinders the chaperone-Start network and arrests cells in G1". In line with this, the end of the Abstract has been modified to clarify the idea of a "molecular pathway postulating proteostasis decay as a key contributing effector of cell senescence." In addition, although we had already addressed this point in our paper, the Discussion section has also been modified to emphasize the existence of other mechanisms as follows: "\[...\], the inability of chaperone overexpression to extend lifespan would also underscore the existence of chaperone-independent mechanisms affecting execution of Start in aged cells as above mentioned, such as ERC-mediated downregulation of G1/S genes (Neurohr et al., 2018)."

> 2\) It raises issues about the interpretation of how Cln3 over-expression promotes longevity. Indeed, if proteostasis collapse is the lethal event, how would cell cycle progression allow cells to escape it, in the context of your model of an exponential accumulation of unfolded proteins?
>
> Therefore, the reviewers decided to insist on their request that you investigate whether CLN3 over-expression promotes chaperon expression. If this were not to be the case, the reviewers would find it more appropriate to discuss the issue more thoroughly and tone down the main conclusion of the paper.

Regarding your second point, we would like to point out that *CLN3* overexpression fully suppresses the requirement of the Ydj1 chaperone for cell cycle entry in young cells, with no effects on the expression of related chaperones (Vergés et al., 2007). We had interpreted this result as if retention of Cln3 at the ER was not a very efficient mechanism and could not cope with very high levels of translated Cln3. In any event, the above suppression would explain why, even if proteostasis is seriously affecting chaperone availability in very old cells, high levels of Cln3 would suffice to prolong replicative lifespan. We have added this comment to the Discussion section (paragraph five).
